| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 15 | 2012 | 336 | 1.730 |
Why?
|
| Phenotype | 17 | 2016 | 947 | 1.200 |
Why?
|
| Abnormalities, Multiple | 11 | 2016 | 109 | 1.150 |
Why?
|
| Child, Preschool | 38 | 2019 | 3187 | 1.020 |
Why?
|
| Muscle Hypotonia | 10 | 2015 | 19 | 1.000 |
Why?
|
| Developmental Disabilities | 7 | 2016 | 119 | 0.970 |
Why?
|
| Mutation | 13 | 2016 | 1213 | 0.960 |
Why?
|
| Honduras | 14 | 2017 | 21 | 0.940 |
Why?
|
| Chromosomes, Human, X | 5 | 2011 | 24 | 0.930 |
Why?
|
| Chromosome Deletion | 5 | 2014 | 41 | 0.900 |
Why?
|
| Child | 41 | 2017 | 6405 | 0.860 |
Why?
|
| Complementary Therapies | 2 | 2015 | 43 | 0.820 |
Why?
|
| Sequence Deletion | 3 | 2011 | 89 | 0.790 |
Why?
|
| Infant | 29 | 2017 | 2891 | 0.730 |
Why?
|
| Chromosome Disorders | 2 | 2012 | 31 | 0.710 |
Why?
|
| Mental Retardation, X-Linked | 3 | 2015 | 16 | 0.680 |
Why?
|
| Anticonvulsants | 10 | 2010 | 223 | 0.660 |
Why?
|
| Medication Adherence | 2 | 2015 | 335 | 0.650 |
Why?
|
| Seizures, Febrile | 4 | 2008 | 10 | 0.650 |
Why?
|
| Brain | 15 | 2019 | 2176 | 0.640 |
Why?
|
| Humans | 94 | 2019 | 68618 | 0.630 |
Why?
|
| Male | 66 | 2019 | 37321 | 0.590 |
Why?
|
| Microcephaly | 2 | 2014 | 6 | 0.590 |
Why?
|
| Chikungunya virus | 1 | 2017 | 3 | 0.590 |
Why?
|
| Chikungunya Fever | 1 | 2017 | 3 | 0.590 |
Why?
|
| Child, Hospitalized | 1 | 2017 | 16 | 0.580 |
Why?
|
| Neurodegenerative Diseases | 3 | 2019 | 102 | 0.580 |
Why?
|
| Nervous System Diseases | 3 | 2017 | 142 | 0.570 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2017 | 2223 | 0.570 |
Why?
|
| Female | 60 | 2017 | 38074 | 0.540 |
Why?
|
| Neurologic Examination | 5 | 2017 | 107 | 0.530 |
Why?
|
| Intellectual Disability | 11 | 2014 | 114 | 0.530 |
Why?
|
| Cerebellar Nuclei | 1 | 2015 | 11 | 0.520 |
Why?
|
| Medicine, Traditional | 1 | 2015 | 7 | 0.510 |
Why?
|
| Globus Pallidus | 1 | 2015 | 64 | 0.500 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 35 | 0.500 |
Why?
|
| Gadolinium | 1 | 2015 | 88 | 0.490 |
Why?
|
| Chromosome Aberrations | 3 | 2011 | 86 | 0.490 |
Why?
|
| Infant, Newborn | 22 | 2017 | 2455 | 0.490 |
Why?
|
| Adolescent | 22 | 2019 | 8912 | 0.490 |
Why?
|
| Neurocysticercosis | 2 | 2011 | 4 | 0.440 |
Why?
|
| Translocation, Genetic | 2 | 2012 | 74 | 0.430 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2010 | 786 | 0.420 |
Why?
|
| Chromosomes, Human, Y | 1 | 2012 | 13 | 0.420 |
Why?
|
| Status Epilepticus | 2 | 2010 | 74 | 0.410 |
Why?
|
| Trisomy | 1 | 2012 | 47 | 0.410 |
Why?
|
| Neurosciences | 1 | 2012 | 15 | 0.410 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2011 | 1 | 0.410 |
Why?
|
| Contrast Media | 1 | 2015 | 595 | 0.400 |
Why?
|
| Fragile X Syndrome | 1 | 2011 | 17 | 0.400 |
Why?
|
| Developing Countries | 3 | 2010 | 106 | 0.400 |
Why?
|
| Gene Duplication | 1 | 2011 | 12 | 0.380 |
Why?
|
| DNA Mutational Analysis | 8 | 2010 | 159 | 0.380 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2012 | 148 | 0.360 |
Why?
|
| Myotonia Congenita | 1 | 2010 | 1 | 0.360 |
Why?
|
| Mucolipidoses | 1 | 2010 | 2 | 0.360 |
Why?
|
| Chloride Channels | 1 | 2010 | 22 | 0.360 |
Why?
|
| Body Size | 1 | 2010 | 39 | 0.350 |
Why?
|
| Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2009 | 2 | 0.350 |
Why?
|
| Carbamazepine | 1 | 2010 | 108 | 0.350 |
Why?
|
| CpG Islands | 1 | 2010 | 51 | 0.350 |
Why?
|
| Autistic Disorder | 1 | 2011 | 77 | 0.350 |
Why?
|
| Head | 2 | 2010 | 59 | 0.350 |
Why?
|
| Population Surveillance | 2 | 2011 | 285 | 0.350 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2009 | 4 | 0.350 |
Why?
|
| Blood Chemical Analysis | 1 | 2009 | 43 | 0.340 |
Why?
|
| Neonatal Screening | 1 | 2009 | 43 | 0.340 |
Why?
|
| Eye Abnormalities | 3 | 2008 | 15 | 0.340 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2009 | 2 | 0.340 |
Why?
|
| Methemoglobinemia | 1 | 2009 | 6 | 0.340 |
Why?
|
| Gene Deletion | 3 | 2019 | 235 | 0.330 |
Why?
|
| Muscle Hypertonia | 1 | 2008 | 1 | 0.330 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 772 | 0.330 |
Why?
|
| Receptors, Glycine | 1 | 2008 | 9 | 0.330 |
Why?
|
| Reflex, Abnormal | 1 | 2008 | 6 | 0.330 |
Why?
|
| Pedigree | 8 | 2017 | 159 | 0.320 |
Why?
|
| Residence Characteristics | 1 | 2011 | 252 | 0.320 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2008 | 3 | 0.320 |
Why?
|
| Syndactyly | 1 | 2008 | 4 | 0.320 |
Why?
|
| Tooth Abnormalities | 1 | 2008 | 3 | 0.320 |
Why?
|
| Adult | 22 | 2015 | 21403 | 0.320 |
Why?
|
| Craniofacial Abnormalities | 1 | 2008 | 18 | 0.320 |
Why?
|
| Seizures | 9 | 2010 | 279 | 0.310 |
Why?
|
| Prader-Willi Syndrome | 1 | 2008 | 1 | 0.310 |
Why?
|
| Butyryl-CoA Dehydrogenase | 1 | 2008 | 1 | 0.310 |
Why?
|
| Suppression, Genetic | 1 | 2008 | 10 | 0.310 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2008 | 5 | 0.310 |
Why?
|
| alpha-Mannosidosis | 1 | 2007 | 1 | 0.310 |
Why?
|
| Growth Disorders | 1 | 2008 | 21 | 0.300 |
Why?
|
| Sturge-Weber Syndrome | 2 | 2006 | 5 | 0.300 |
Why?
|
| Connexin 43 | 1 | 2008 | 62 | 0.300 |
Why?
|
| Cerebral Veins | 2 | 2006 | 6 | 0.300 |
Why?
|
| Nervous System Malformations | 1 | 2007 | 7 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2007 | 18 | 0.300 |
Why?
|
| Spasms, Infantile | 2 | 1997 | 6 | 0.290 |
Why?
|
| Genes, Dominant | 3 | 2016 | 51 | 0.290 |
Why?
|
| Hemangioma | 3 | 2004 | 51 | 0.280 |
Why?
|
| Mutation, Missense | 4 | 2010 | 112 | 0.280 |
Why?
|
| Hydrocephalus | 3 | 2006 | 40 | 0.270 |
Why?
|
| Retinoschisis | 1 | 2006 | 2 | 0.270 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2006 | 15 | 0.270 |
Why?
|
| Glaucoma | 1 | 2006 | 50 | 0.260 |
Why?
|
| Quadriplegia | 2 | 2008 | 29 | 0.250 |
Why?
|
| Interleukin-1 | 1 | 2005 | 86 | 0.250 |
Why?
|
| Eye Proteins | 1 | 2006 | 160 | 0.250 |
Why?
|
| Facial Neoplasms | 2 | 2004 | 10 | 0.240 |
Why?
|
| Brain Diseases | 3 | 2008 | 78 | 0.240 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2004 | 3 | 0.240 |
Why?
|
| Heart Septal Defects | 1 | 2004 | 27 | 0.240 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2004 | 10 | 0.240 |
Why?
|
| Gene Expression | 1 | 2006 | 770 | 0.220 |
Why?
|
| Cohort Studies | 4 | 2015 | 2358 | 0.210 |
Why?
|
| Rural Population | 2 | 2009 | 398 | 0.210 |
Why?
|
| Folic Acid Deficiency | 1 | 2002 | 16 | 0.210 |
Why?
|
| Energy Intake | 1 | 2002 | 123 | 0.190 |
Why?
|
| Syndrome | 7 | 2012 | 255 | 0.190 |
Why?
|
| Central Nervous System | 2 | 2019 | 107 | 0.190 |
Why?
|
| Genetic Diseases, X-Linked | 3 | 2013 | 24 | 0.190 |
Why?
|
| Young Adult | 6 | 2016 | 5717 | 0.190 |
Why?
|
| Obesity | 1 | 2008 | 1076 | 0.190 |
Why?
|
| Follow-Up Studies | 10 | 2011 | 3259 | 0.180 |
Why?
|
| Health Surveys | 2 | 2015 | 489 | 0.180 |
Why?
|
| Asphyxia Neonatorum | 2 | 1999 | 14 | 0.180 |
Why?
|
| Birth Injuries | 1 | 1999 | 3 | 0.180 |
Why?
|
| GABA Antagonists | 1 | 1999 | 22 | 0.170 |
Why?
|
| Nipecotic Acids | 1 | 1999 | 11 | 0.170 |
Why?
|
| Delivery, Obstetric | 1 | 1999 | 58 | 0.170 |
Why?
|
| Interferon-beta | 1 | 1999 | 17 | 0.170 |
Why?
|
| Age Distribution | 3 | 2017 | 320 | 0.170 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2019 | 3 | 0.170 |
Why?
|
| South Carolina | 4 | 2017 | 2752 | 0.170 |
Why?
|
| Adjuvants, Immunologic | 1 | 1999 | 63 | 0.170 |
Why?
|
| Intracranial Hemorrhages | 1 | 1999 | 80 | 0.170 |
Why?
|
| Exons | 2 | 2010 | 122 | 0.170 |
Why?
|
| Treatment Outcome | 6 | 2010 | 7029 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 3 | 2011 | 492 | 0.160 |
Why?
|
| Fructose | 1 | 1999 | 51 | 0.160 |
Why?
|
| Pluripotent Stem Cells | 1 | 2019 | 42 | 0.160 |
Why?
|
| Genetic Linkage | 5 | 2006 | 90 | 0.160 |
Why?
|
| Genotype | 3 | 2016 | 786 | 0.160 |
Why?
|
| Hypothermia, Induced | 1 | 1999 | 93 | 0.160 |
Why?
|
| X Chromosome | 4 | 2002 | 28 | 0.160 |
Why?
|
| Cilia | 2 | 2009 | 94 | 0.150 |
Why?
|
| Basal Ganglia Diseases | 1 | 1998 | 13 | 0.150 |
Why?
|
| Meningomyelocele | 1 | 2017 | 11 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2017 | 7277 | 0.150 |
Why?
|
| Receptors, Cell Surface | 1 | 2019 | 248 | 0.150 |
Why?
|
| Multiple Sclerosis | 1 | 1999 | 132 | 0.150 |
Why?
|
| Transcription Factors | 2 | 2016 | 753 | 0.150 |
Why?
|
| Genetic Testing | 4 | 2017 | 159 | 0.150 |
Why?
|
| Tuberous Sclerosis | 1 | 1997 | 13 | 0.150 |
Why?
|
| Chromosome Mapping | 4 | 2011 | 188 | 0.150 |
Why?
|
| Genes, Viral | 1 | 2017 | 44 | 0.150 |
Why?
|
| Dipeptidases | 1 | 1997 | 1 | 0.150 |
Why?
|
| Early Diagnosis | 2 | 2007 | 122 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1997 | 17 | 0.140 |
Why?
|
| Tremor | 1 | 1997 | 16 | 0.140 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1997 | 106 | 0.140 |
Why?
|
| Middle Aged | 8 | 2013 | 21147 | 0.140 |
Why?
|
| Cysts | 1 | 1997 | 70 | 0.140 |
Why?
|
| Dwarfism | 1 | 2016 | 5 | 0.140 |
Why?
|
| Valproic Acid | 1 | 1997 | 93 | 0.140 |
Why?
|
| Aged | 6 | 2011 | 14862 | 0.140 |
Why?
|
| Sick Role | 1 | 1996 | 40 | 0.140 |
Why?
|
| Image Enhancement | 1 | 1997 | 143 | 0.140 |
Why?
|
| Infant, Newborn, Diseases | 5 | 1982 | 91 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 2 | 2013 | 182 | 0.130 |
Why?
|
| Rural Health Services | 1 | 2017 | 101 | 0.130 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1998 | 250 | 0.130 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 1995 | 10 | 0.130 |
Why?
|
| Kernicterus | 1 | 1995 | 7 | 0.130 |
Why?
|
| Myoclonus | 1 | 1995 | 9 | 0.130 |
Why?
|
| Anemia, Hemolytic | 1 | 1995 | 37 | 0.130 |
Why?
|
| Pilot Projects | 3 | 2009 | 1342 | 0.130 |
Why?
|
| Abdominal Neoplasms | 1 | 1995 | 22 | 0.130 |
Why?
|
| Ocular Motility Disorders | 1 | 1995 | 15 | 0.130 |
Why?
|
| Recurrence | 6 | 2006 | 948 | 0.130 |
Why?
|
| Dystonia | 1 | 2015 | 18 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 234 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2017 | 211 | 0.120 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 99 | 0.120 |
Why?
|
| Drug Therapy | 1 | 2015 | 71 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2014 | 18 | 0.120 |
Why?
|
| Chromosome Duplication | 1 | 2014 | 2 | 0.120 |
Why?
|
| Pediatrics | 2 | 2008 | 341 | 0.120 |
Why?
|
| Neoplasms, Second Primary | 1 | 1995 | 62 | 0.120 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2014 | 40 | 0.120 |
Why?
|
| Bone and Bones | 1 | 2015 | 145 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 15 | 0.120 |
Why?
|
| Megalencephaly | 1 | 2014 | 3 | 0.120 |
Why?
|
| Age Factors | 4 | 2010 | 1864 | 0.120 |
Why?
|
| Language Disorders | 1 | 2014 | 22 | 0.120 |
Why?
|
| Blepharophimosis | 1 | 2014 | 2 | 0.120 |
Why?
|
| Carrier Proteins | 2 | 2017 | 597 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 1995 | 109 | 0.120 |
Why?
|
| Skin Abnormalities | 1 | 2014 | 11 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2014 | 56 | 0.120 |
Why?
|
| raf Kinases | 1 | 2013 | 6 | 0.110 |
Why?
|
| Noonan Syndrome | 1 | 2013 | 6 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2015 | 211 | 0.110 |
Why?
|
| Agenesis of Corpus Callosum | 2 | 2005 | 5 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 955 | 0.110 |
Why?
|
| Adaptation, Psychological | 1 | 1996 | 447 | 0.110 |
Why?
|
| Sjogren-Larsson Syndrome | 1 | 2012 | 2 | 0.110 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2012 | 10 | 0.110 |
Why?
|
| Fatal Outcome | 2 | 2010 | 164 | 0.110 |
Why?
|
| Reference Values | 3 | 2010 | 579 | 0.110 |
Why?
|
| Sex Chromosomes | 1 | 2012 | 4 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2012 | 23 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 700 | 0.100 |
Why?
|
| Haplotypes | 2 | 2010 | 174 | 0.100 |
Why?
|
| Epilepsy, Generalized | 1 | 1992 | 15 | 0.100 |
Why?
|
| Epilepsies, Partial | 1 | 1992 | 24 | 0.100 |
Why?
|
| Genes, Duplicate | 1 | 2011 | 2 | 0.100 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2011 | 2 | 0.100 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 10 | 0.100 |
Why?
|
| Prognosis | 5 | 2009 | 2093 | 0.100 |
Why?
|
| DNA Primers | 2 | 2010 | 302 | 0.100 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2011 | 20 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 15 | 0.100 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2011 | 13 | 0.100 |
Why?
|
| Iron | 1 | 2013 | 197 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 114 | 0.100 |
Why?
|
| Schools, Medical | 1 | 2012 | 157 | 0.090 |
Why?
|
| Pregnancy | 6 | 2010 | 2334 | 0.090 |
Why?
|
| Genes, Recessive | 1 | 2010 | 18 | 0.090 |
Why?
|
| Curriculum | 2 | 2012 | 575 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2012 | 254 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2006 | 181 | 0.090 |
Why?
|
| Jews | 1 | 2010 | 7 | 0.090 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2010 | 5 | 0.090 |
Why?
|
| TRPM Cation Channels | 1 | 2010 | 5 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2011 | 238 | 0.090 |
Why?
|
| Paralysis | 2 | 2003 | 35 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 271 | 0.090 |
Why?
|
| Carnitine | 1 | 2009 | 17 | 0.090 |
Why?
|
| Age of Onset | 1 | 2010 | 188 | 0.090 |
Why?
|
| Students, Medical | 1 | 2012 | 210 | 0.090 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2009 | 9 | 0.090 |
Why?
|
| Blood Specimen Collection | 1 | 2009 | 17 | 0.090 |
Why?
|
| Monocarboxylic Acid Transporters | 2 | 2008 | 15 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 1995 | 561 | 0.080 |
Why?
|
| Dyskinesias | 1 | 2009 | 8 | 0.080 |
Why?
|
| Metabolic Diseases | 1 | 2009 | 37 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2009 | 45 | 0.080 |
Why?
|
| Data Collection | 1 | 2011 | 420 | 0.080 |
Why?
|
| Microarray Analysis | 3 | 2014 | 63 | 0.080 |
Why?
|
| Swine | 1 | 2011 | 672 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2009 | 132 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Electroencephalography | 4 | 2005 | 418 | 0.080 |
Why?
|
| Telemedicine | 1 | 2017 | 700 | 0.080 |
Why?
|
| Ketone Bodies | 1 | 2008 | 5 | 0.080 |
Why?
|
| Proline | 1 | 2008 | 52 | 0.080 |
Why?
|
| Meat Products | 1 | 2008 | 8 | 0.080 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2008 | 4 | 0.080 |
Why?
|
| Paraplegia | 1 | 2008 | 28 | 0.080 |
Why?
|
| Inpatients | 1 | 2010 | 208 | 0.080 |
Why?
|
| Penetrance | 1 | 2008 | 17 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 2279 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 208 | 0.080 |
Why?
|
| Muscle Spasticity | 3 | 2008 | 11 | 0.080 |
Why?
|
| Vitamins | 1 | 2009 | 134 | 0.080 |
Why?
|
| Family Health | 1 | 2008 | 83 | 0.080 |
Why?
|
| Arginine | 1 | 2008 | 102 | 0.080 |
Why?
|
| Outpatients | 1 | 2009 | 127 | 0.080 |
Why?
|
| Sex Chromosome Disorders | 1 | 2008 | 1 | 0.080 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2008 | 1 | 0.080 |
Why?
|
| Disease Progression | 2 | 2011 | 1038 | 0.080 |
Why?
|
| Genetic Counseling | 1 | 2008 | 45 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Animals | 5 | 2019 | 20881 | 0.080 |
Why?
|
| Spermine Synthase | 2 | 2008 | 12 | 0.080 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 2006 | 18 | 0.080 |
Why?
|
| Mothers | 1 | 2009 | 172 | 0.080 |
Why?
|
| Social Values | 1 | 2007 | 34 | 0.070 |
Why?
|
| Physicians, Women | 1 | 2007 | 23 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2008 | 223 | 0.070 |
Why?
|
| Kyphosis | 1 | 2007 | 18 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2008 | 144 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2010 | 225 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2010 | 402 | 0.070 |
Why?
|
| Skull | 1 | 2007 | 63 | 0.070 |
Why?
|
| Face | 1 | 2007 | 46 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2008 | 137 | 0.070 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2008 | 86 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2008 | 244 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 307 | 0.070 |
Why?
|
| Time Factors | 4 | 2012 | 4655 | 0.070 |
Why?
|
| Sucking Behavior | 1 | 2006 | 8 | 0.070 |
Why?
|
| International Cooperation | 1 | 2006 | 88 | 0.070 |
Why?
|
| Myasthenia Gravis | 1 | 2006 | 17 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 301 | 0.070 |
Why?
|
| Neurology | 1 | 2006 | 43 | 0.070 |
Why?
|
| Connexins | 1 | 2006 | 35 | 0.070 |
Why?
|
| Skin Neoplasms | 3 | 1996 | 375 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2008 | 652 | 0.070 |
Why?
|
| Clinical Enzyme Tests | 1 | 2006 | 6 | 0.070 |
Why?
|
| Membrane Transport Proteins | 2 | 2008 | 81 | 0.070 |
Why?
|
| Cephalometry | 1 | 2006 | 19 | 0.070 |
Why?
|
| Cranial Sinuses | 1 | 2006 | 11 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2006 | 41 | 0.070 |
Why?
|
| Genetic Carrier Screening | 1 | 2006 | 25 | 0.070 |
Why?
|
| Muscular Dystrophies | 1 | 2006 | 17 | 0.070 |
Why?
|
| Orbit | 1 | 2006 | 30 | 0.070 |
Why?
|
| Genitalia, Male | 1 | 2005 | 14 | 0.070 |
Why?
|
| Fibroblasts | 2 | 2012 | 902 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2010 | 617 | 0.060 |
Why?
|
| Cerebral Angiography | 1 | 2006 | 151 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1999 | 1745 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2006 | 228 | 0.060 |
Why?
|
| Cataract | 1 | 2006 | 134 | 0.060 |
Why?
|
| Point-of-Care Systems | 1 | 2006 | 115 | 0.060 |
Why?
|
| Videotape Recording | 1 | 2005 | 43 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2006 | 214 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2010 | 3705 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 157 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2077 | 0.060 |
Why?
|
| Nevus, Pigmented | 2 | 1996 | 30 | 0.060 |
Why?
|
| Leukocytosis | 1 | 2004 | 13 | 0.060 |
Why?
|
| Biogenic Polyamines | 1 | 2003 | 8 | 0.060 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2003 | 8 | 0.060 |
Why?
|
| Mass Screening | 1 | 2009 | 843 | 0.060 |
Why?
|
| Base Sequence | 4 | 2009 | 1015 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2009 | 2800 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 1465 | 0.060 |
Why?
|
| Incidence | 2 | 2005 | 1603 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 1999 | 415 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 767 | 0.050 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2013 | 32 | 0.050 |
Why?
|
| Deglutition Disorders | 1 | 2006 | 297 | 0.050 |
Why?
|
| Alternative Splicing | 2 | 2019 | 93 | 0.050 |
Why?
|
| Cerebral Palsy | 3 | 1997 | 24 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 144 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2005 | 2324 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 4848 | 0.050 |
Why?
|
| United States | 2 | 2010 | 7367 | 0.040 |
Why?
|
| Prevalence | 1 | 2005 | 1619 | 0.040 |
Why?
|
| Genitalia | 1 | 1999 | 5 | 0.040 |
Why?
|
| Hypoxia, Brain | 1 | 1999 | 16 | 0.040 |
Why?
|
| Proton-Translocating ATPases | 1 | 2019 | 9 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 1997 | 1140 | 0.040 |
Why?
|
| Cesarean Section | 1 | 1999 | 101 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 32 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 1999 | 68 | 0.040 |
Why?
|
| Child Development | 1 | 1999 | 102 | 0.040 |
Why?
|
| Neurons | 2 | 2019 | 881 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 237 | 0.040 |
Why?
|
| Lysosomes | 1 | 2019 | 136 | 0.040 |
Why?
|
| Cyanosis | 1 | 1998 | 4 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 329 | 0.040 |
Why?
|
| Gait | 1 | 1999 | 120 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2019 | 220 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 1999 | 567 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 326 | 0.040 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 21 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1998 | 137 | 0.040 |
Why?
|
| Hemiplegia | 2 | 1994 | 29 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 306 | 0.040 |
Why?
|
| Symporters | 2 | 2008 | 27 | 0.040 |
Why?
|
| Facies | 1 | 2016 | 2 | 0.040 |
Why?
|
| Exome | 1 | 2016 | 20 | 0.030 |
Why?
|
| Risk | 3 | 1995 | 563 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1999 | 782 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 103 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 137 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 68 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 901 | 0.030 |
Why?
|
| Psychometrics | 1 | 1999 | 514 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 136 | 0.030 |
Why?
|
| Recovery of Function | 1 | 1999 | 506 | 0.030 |
Why?
|
| Brachial Plexus | 1 | 1995 | 15 | 0.030 |
Why?
|
| Nerve Compression Syndromes | 1 | 1995 | 16 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 1995 | 41 | 0.030 |
Why?
|
| Alleles | 1 | 2016 | 386 | 0.030 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 1995 | 20 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 1996 | 149 | 0.030 |
Why?
|
| Bilirubin | 1 | 1995 | 51 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 502 | 0.030 |
Why?
|
| Porphyria, Erythropoietic | 1 | 1994 | 2 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1034 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 10 | 0.030 |
Why?
|
| Language Tests | 1 | 2014 | 36 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 27 | 0.030 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 3 | 0.030 |
Why?
|
| Internet | 1 | 2017 | 390 | 0.030 |
Why?
|
| Patient Care Team | 1 | 1996 | 311 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 1997 | 342 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 18 | 0.030 |
Why?
|
| Heterozygote | 2 | 2006 | 174 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 442 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 1996 | 425 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 1999 | 665 | 0.030 |
Why?
|
| Mental Disorders | 1 | 1999 | 659 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 1447 | 0.030 |
Why?
|
| Logistic Models | 1 | 1997 | 1420 | 0.030 |
Why?
|
| Ichthyosis | 1 | 2012 | 3 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 223 | 0.030 |
Why?
|
| Nevus | 1 | 1972 | 17 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 2791 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 1992 | 24 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1995 | 446 | 0.030 |
Why?
|
| Intelligence | 1 | 1992 | 45 | 0.030 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 19 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1641 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 1996 | 364 | 0.030 |
Why?
|
| Epinephrine | 1 | 1972 | 103 | 0.030 |
Why?
|
| Intelligence Tests | 2 | 2010 | 32 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1999 | 2550 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 186 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1972 | 276 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 201 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2010 | 43 | 0.020 |
Why?
|
| Eye Movements | 1 | 2010 | 44 | 0.020 |
Why?
|
| Apgar Score | 3 | 1982 | 22 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 1972 | 215 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 572 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1992 | 649 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1970 | 46 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 320 | 0.020 |
Why?
|
| Fetus | 1 | 2009 | 157 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 108 | 0.020 |
Why?
|
| Family | 1 | 2010 | 293 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 67 | 0.020 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2008 | 2 | 0.020 |
Why?
|
| alpha-Thalassemia | 1 | 2008 | 7 | 0.020 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2008 | 12 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 2007 | 22 | 0.020 |
Why?
|
| Social Perception | 1 | 2007 | 44 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 230 | 0.020 |
Why?
|
| Zebrafish | 1 | 2008 | 187 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 8474 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 1851 | 0.020 |
Why?
|
| Physician's Role | 1 | 2007 | 116 | 0.020 |
Why?
|
| Computational Biology | 1 | 2008 | 190 | 0.020 |
Why?
|
| Risk Factors | 2 | 2009 | 5731 | 0.020 |
Why?
|
| Educational Status | 1 | 2007 | 273 | 0.020 |
Why?
|
| Lod Score | 1 | 2006 | 14 | 0.020 |
Why?
|
| Thymine | 1 | 2006 | 3 | 0.020 |
Why?
|
| Models, Educational | 1 | 2006 | 67 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 2006 | 18 | 0.020 |
Why?
|
| Thymectomy | 1 | 2006 | 11 | 0.020 |
Why?
|
| Pyridostigmine Bromide | 1 | 2006 | 11 | 0.020 |
Why?
|
| Guanine | 1 | 2006 | 21 | 0.020 |
Why?
|
| Child Day Care Centers | 1 | 2006 | 25 | 0.020 |
Why?
|
| Pneumonia, Aspiration | 1 | 2006 | 22 | 0.020 |
Why?
|
| Muscle Fatigue | 1 | 2006 | 16 | 0.020 |
Why?
|
| Cholinergic Antagonists | 1 | 2006 | 17 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2006 | 123 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2006 | 65 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2006 | 49 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 290 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2006 | 110 | 0.020 |
Why?
|
| Blood Glucose | 2 | 2004 | 631 | 0.020 |
Why?
|
| Tyrosine | 1 | 2006 | 196 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1266 | 0.020 |
Why?
|
| Program Development | 1 | 2006 | 240 | 0.020 |
Why?
|
| Life Style | 1 | 2007 | 338 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2009 | 1664 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 581 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2004 | 42 | 0.010 |
Why?
|
| Israel | 1 | 2004 | 26 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2004 | 53 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2004 | 94 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 951 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2004 | 169 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 711 | 0.010 |
Why?
|
| Body Temperature | 1 | 2004 | 116 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 274 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2004 | 114 | 0.010 |
Why?
|
| Neutrophils | 1 | 2004 | 204 | 0.010 |
Why?
|
| Introns | 1 | 2002 | 68 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 710 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2006 | 468 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 658 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2007 | 596 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 396 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2673 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 1083 | 0.010 |
Why?
|
| Birth Weight | 2 | 1995 | 186 | 0.010 |
Why?
|
| Behavioral Symptoms | 1 | 1999 | 32 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1999 | 51 | 0.010 |
Why?
|
| Brain Neoplasms | 2 | 1972 | 371 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 1996 | 47 | 0.010 |
Why?
|
| Muscles | 1 | 1995 | 158 | 0.010 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 1975 | 1 | 0.010 |
Why?
|
| Phenobarbital | 1 | 1975 | 25 | 0.010 |
Why?
|
| Diazepam | 1 | 1975 | 23 | 0.010 |
Why?
|
| Hypocalcemia | 1 | 1975 | 13 | 0.010 |
Why?
|
| Phenytoin | 1 | 1975 | 27 | 0.010 |
Why?
|
| Meningitis | 1 | 1975 | 23 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 1753 | 0.010 |
Why?
|
| Magnesium | 1 | 1975 | 110 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 1975 | 72 | 0.010 |
Why?
|
| Medroxyprogesterone | 1 | 1973 | 3 | 0.010 |
Why?
|
| Menstruation Disturbances | 1 | 1973 | 3 | 0.010 |
Why?
|
| Menstruation | 1 | 1973 | 20 | 0.010 |
Why?
|
| Plasma | 1 | 1972 | 58 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 1972 | 88 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1972 | 19 | 0.010 |
Why?
|
| Hypercapnia | 1 | 1972 | 17 | 0.010 |
Why?
|
| Umbilical Arteries | 1 | 1972 | 9 | 0.010 |
Why?
|
| Blood | 1 | 1972 | 40 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1972 | 54 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1972 | 41 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1972 | 48 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1972 | 57 | 0.010 |
Why?
|
| Salivary Gland Neoplasms | 1 | 1972 | 40 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 1972 | 31 | 0.010 |
Why?
|
| Sepsis | 1 | 1975 | 233 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 1972 | 150 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1972 | 205 | 0.010 |
Why?
|
| Eye Neoplasms | 1 | 1970 | 10 | 0.010 |
Why?
|
| Lip Neoplasms | 1 | 1970 | 12 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1972 | 618 | 0.010 |
Why?
|
| Tongue Neoplasms | 1 | 1970 | 29 | 0.010 |
Why?
|
| Hamartoma | 1 | 1970 | 24 | 0.010 |
Why?
|
| Heart Neoplasms | 1 | 1970 | 33 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1970 | 40 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 1970 | 64 | 0.010 |
Why?
|
| Pre-Eclampsia | 1 | 1972 | 202 | 0.010 |
Why?
|
| Steroids | 1 | 1970 | 84 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1970 | 122 | 0.010 |
Why?
|
| Skin | 1 | 1972 | 451 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1970 | 206 | 0.010 |
Why?
|
| Kidney | 1 | 1972 | 945 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1970 | 334 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1985 | 1040 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1972 | 1536 | 0.000 |
Why?
|
| Resuscitation | 1 | 1982 | 77 | 0.000 |
Why?
|
| Probability | 1 | 1982 | 245 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1970 | 1173 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1981 | 601 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1973 | 31 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1973 | 29 | 0.000 |
Why?
|
| Cetylpyridinium | 1 | 1972 | 1 | 0.000 |
Why?
|
| Mucopolysaccharidoses | 1 | 1972 | 2 | 0.000 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 1972 | 6 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1972 | 79 | 0.000 |
Why?
|
| Creatine | 1 | 1972 | 30 | 0.000 |
Why?
|
| Retinitis Pigmentosa | 1 | 1972 | 17 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1972 | 358 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1972 | 186 | 0.000 |
Why?
|